Follow Rediff on:

rediff.com
Rediffmail Money rediffGURUS BusinessEmail
August 13, 2025 IST 14:16:37

Rediff-TV 📺

This browser does not support the video element.

Disclaimer: This image is entirely AI-generated and is a product of artificial intelligence. Any resemblance to actual persons, whether living or deceased, is purely coincidental and unintentional.
1 day ago

Duration: 0h 5m 17s

25% Donald Trump tariff likely to weigh on pharma margins: Analysts

If pharmaceutical exports from India to the US come under a 25 per cent tariff bracket, the impact on earnings before interest, tax, depreciation and amortisation (Ebitda) could be around 5 per cent, felt analysts. This is after assuming that about 75 per cent of the tariff would be passed on.

Uploaded by: Rediff Video Desk on Tue, 12 Aug 2025 12:47:46 +0530

Views: 2

Tags: 25% Donald Trump tariff likely to weigh on pharma margins: Analysts

Watch More Videos

NEWS

Will teach India lesson it will never forget if...: Pak PM

3 hours ago

See More >

MOVIES

He Quit Amazon To Make Films

3 hours ago

See More >

BUSINESS

From Badla To Jane Street: Market Tricks Haunt Again

3 hours ago

See More >

GET AHEAD

When Workplace Stress Turns Deadly

3 hours ago

Gorgeous Gouri!

1 day ago
See More >

CRICKET

Fans rage as Pakistan lose 1st WI ODI series in 30 years

2 hours ago

See More >

SPORTS

SC rejects bail for wrestler Sushil Kumar

2 hours ago

See More >

hourly

2 pm News Flash – August 13, 2025

14 minutes ago

See More >
© 2025 Rediff.com - Feedback - About us - Grievances - Advertise with us